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a b s t r a c t
Masson's tumor, also known as intravascular papillary endothelial hyperplasia (IPEH), is a rare and benign vascular disease in which there is a reactive hyperplasia of intravascular endothelial cells. This tumor is most commonly found in soft tissues in the head, neck and upper extremities. We report a rare case of IPEH on the vulva. A
Hispanic woman in her mid-thirties presented with a painful and pruritic left vulvar mass. On physical examination, a pedunculated mass was visualized on the left labia majora. Under pathologic examination, it was concluded the lesion was IPEH and it was surgically excised. This is a rare case of IPEH located on the vulva.
However, despite this rarity, a simple local excision could be used to manage IPEH.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction
Intravascular papillary endothelial hyperplasia, also known as
Masson's tumor, is a rare tumor that affects intravascular endothelial
cells [1]. It is usually found in soft tissues of the head, neck and upper extremities [2]. It is best treated with complete surgical resection [3]. We
report a case of intravascular papillary endothelial hyperplasia of the
vulva which was successfully managed by complete surgical excision.
2. Case Presentation
A Hispanic woman in her mid-thirties, gravida 0, with a history of bipolar disorder, presented with a chief complaint of a left vulvar mass for
one year. She described the lesion as “purplish” and complained of tenderness to the touch. The mass had increased in size over the course of
the year along with worsening pain.
Previous evaluation ruled out herpes simplex virus and the leading
differential diagnosis was vulvar varicosities based on the appearance
and characteristics on examination. She was treated accordingly with
conservative measures and topical hydrocortisone cream for the
discomfort.
Due to increasing size and pain, however, she sought re-evaluation.
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Her medical history was non-contributory, and she was up to date
on recommended health maintenance evaluations.
On examination, a pedunculated mass was identiﬁed on the left labia
majora (Fig. 1). It was grayish to tan brown in color, and it measured approximately 2 cm × 3 cm. The mass surface had exposed, granulation
tissue and a well demarcated outline near the base. The surface appeared irregular and wrinkled. Central areas of hemorrhagic tissue necrosis were also noted. The mass and base had minimal tenderness to
palpation. Tender lymph nodes were identiﬁed on the left groin, with
no evidence of excoriations. Vaginal exam demonstrated copious
white discharge, without a foul smell. The rest of the pelvic examination
did not reveal any related abnormalities.
Clinical biopsy revealed granulation tissue with acute and chronic
inﬂammation. Additional testing was negative for human apillomavirus
16 and 18 and fungi by special stain. Vaginal discharge was collected
and tested positive for bacterial vaginosis. She was prescribed metronidazole. Blood samples were taken and tested for syphilis and human immunodeﬁciency virus and results were negative. The mass was excised
in the operating room.
Under pathologic examination, a well-circumscribed lesion, with
characteristic papillary fronds, was visualized. The proliferative process
was entirely limited to the intravascular spaces. The papillae were composed of ﬁbrohyalinized tissue of two or more endothelial cell layers.
Individual endothelial cells showed mild hyperchromasia and mild
nuclear atypia; however, mitotic ﬁgures were not easily identiﬁed. It
was concluded that the lesion was intravascular papillary endothelial
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Fig. 1. Gross images of vulvar lesion.

hyperplasia (Fig. 2). The patient recovered uneventfully without evidence of recurrence.
3. Discussion
Masson's tumor was ﬁrst discovered by Pierre Masson in 1923. Masson
initially named the tumor vegetant intravascular hemangioendothelioma
and described it as a neoplasm [1]. In 1929, Folke Henschen re-described
it as a reactive process instead of a neoplasm and named the lesion
endovasculite proliférante thrombopoïétique [4]. Later, in 1976, the lesion
was renamed intravascular papillary endothelial hyperplasia (IPEH) by
Kevin Clearkin and Dr. Franz Enzinger [5]. IPEH, or Masson's tumor, is a
rare and benign vascular disease in which there is a reactive hyperplasia
of intravascular endothelial cells [1]. It consists of an intravascular proliferation of numerous papillae with a core of connective tissue and an endothelial surface [6]. This tumor is most commonly found in soft tissues in
the head, neck and upper extremities, but it can affect any part of the
body [2].
Masson's tumor can be classiﬁed into three types: the primary or
pure form, the secondary or mixed form, and the extravascular form
[7]. The primary/pure form, which is the most common form, typically
occurs in a dilated vessel, most usually a vein rather than an artery,

and arises in subcutaneous soft tissue [8]. The secondary/mixed presents in preexisting vascular abnormalities. Finally, the extravascular
form, which is the least common form, occurs in hematomas [9].
Masson's tumor can be mistaken for other subcutaneous tumors,
such as lipomas, angiomas, vascular malformations, and cysts. However,
it most commonly resembles, and can be mistaken for, an angiosarcoma
[10]. It is important to differentiate between IPEH and these other conditions. This is done through a clinical and histological diagnostic workup [11]. Clinically, Masson's tumor will appear as a ﬁrm or soft surface
nodule, blue-red in color, and non-pulsatile [11]. Histologically, it will
be characterized by proliferating endothelium lining papillary and anastomosing channel-like structures [12]. In addition, it will not have any
features of malignancy, such as necrosis, cellular atypia, and mitotic ﬁgures, which helps to distinguish it from the similar angiosarcoma [10].
Immunohistochemical conﬁrmation may be required only if the endothelial origin of the lesion is in question [13]. In such cases, endothelial cell markers, such as von Willebrand factor, CD31, factor XIIIa, and
CD43, may be used, which would highlight the endothelial lining
around the papillary tufts [13].
There are many theories regarding Masson's tumor's cause and
pathogenesis, but ultimately it is unknown [14]. Risk factors include history of local trauma or previous vascular conditions (i.e. hemangiomas,
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Fig. 2. Histopathology images of the dissected lesion. A. in 10× - Sections show dilated vessel containing papillary proliferation of plump endothelial cells without atypia. B. in 20× - Fibrin
deposition and thrombi are present. C. in 40× - There is variable nuclear pleomorphism. No mitotic ﬁgures, no necrosis, no solid cellular areas are present.

blood stasis, etc.). Most of the time it will be idiopathic [14]. Women are
at a higher risk than men of acquiring Masson's tumor15. It can affect all
age groups and has no race or ethnic group preferences [15].
Treatment of Masson's tumor consists of complete surgical resection
in order to decrease the risk of recurrence [3]. It has a good prognosis,
with no evidence of local invasion or metastasis [16].
This is a rare case of a patient with intravascular papillary endothelial hyperplasia, also known as Masson's tumor, located on the vulva.
IPEH is typically found in the head, neck and upper extremities. It can
be found in other places on the body, but it is rare to ﬁnd in the genital
region. To our knowledge, there is only one case of IPEH located on the
vulva, which was described by Beutler and Cohen in 2016 [17]. Beutler
and Cohen described IPEH as an organizing thrombus in the vascular
lumen with accompanying hyperplastic endothelial cell proliferation
and reiterated the rarity of Masson's tumor being located on the vulva,
as opposed to the typical areas, such as the head and the limbs. However, despite this rarity, a simple local excision can always be used to
manage Masson's tumor [17].

4. Conclusion
The importance of IPEH lies in the fact that it histologically simulates
angiosarcoma. The lack of cytologic atypia as well as lack of necrosis
help to differentiate it from angiosarcoma. Moreover, IPEH tends to

recur if incompletely resected. Correct diagnosis of this entity is essential to prevent aggressive treatment.
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